B3GAT1 and cancer: Nevertheless, our findings indicated reduced relative expression of CD57 in cancers with poorer prognoses (implied by vascular invasion), which was in contrast to Nasir et al. [12] who reported increased CD57 cells in follicular carcinoma—which had vascular invasion—compared to follicular adenoma (which does not have vascular invasion).